Results 191 to 200 of about 59,389 (246)

Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib's efficacy. [PDF]

Sci Rep
Faleti OD, Alsaadawe M, Long J, Luo Q, Hu L, Zhang Y, Deng S, Wu G, Fang W, He M, Lyu X.   +10 more
europepmc   +1 more source

MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis

, 2014
Robert N. Booher, Harold Hatch, Brian Dolinski, Thi Phuong Nguyen, Lauren Harmonay, Ali-Samer Al-Assaad, Mark Ayers, Michael Nebozhyn, Andrey Loboda, Heather A. Hirsch, Theresa Zhang, Bin Shi, C. Merkel, Minilik Angagaw, Yaolin Wang, Brian J. Long, Xianlu Q. Lennon, Nathan R. Miselis, Vincenzo Pucci, James W. Monahan, Junghoon Lee, Anna Kondic, Eun Kyung Im, David Mauro, Rebecca Blanchard, Gary Gilliland, Stephen E. Fawell, Leigh Zawel, Alwin G. Schuller, Peter R. Strack   +29 more
openalex   +2 more sources

Platelet aging and desialylation increase apoptotic priming and BCL-X_L dependence. [PDF]

Cell Death Dis
Grozovsky R, Fraser CS, Qin X, Spetz J, Sarosiek KA.   +4 more
europepmc   +1 more source

Dual Targeting of Aurora-A and Bcl-xL Synergistically Reshapes the Immune Microenvironment and Induces Apoptosis in Breast Cancer. [PDF]

Cancer Sci
Liu M, Guo J, Liu W, Yang Z, Yu F.
europepmc   +1 more source

Phosphorylation of Rad9 at Serine 328 by Cyclin A-Cdk2 Triggers Apoptosis via Interfering Bcl-xL

, 2012
Zhan Zhuo, Kan He, Dan Zhu, Dan Jiang, Yinghui Huang, Li Yang, Chao Sun, Ying‐Hua Jin   +7 more
openalex   +2 more sources

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function. [PDF]

Biomedicines
Perez-Serna AA, Guzman-Llorens D, Dos Santos RS, Marroqui L.   +3 more
europepmc   +1 more source

Retraction: Protein Isoaspartate Methyltransferase Prevents Apoptosis Induced by Oxidative Stress in Endothelial Cells: Role of Bcl-Xl Deamidation and Methylation

, 2018
The PLOS ONE Editors
openalex   +2 more sources

Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors. [PDF]

Mol Cancer
Senent Y, Fresquet V, Jiménez V, Valencia K, Exposito F, Martín-Úriz PS, Camps G, Fernández-Pierola E, de Córdoba BR, González-Huarriz M, Tamayo I, Remírez A, Moreno H, Serrano D, Ajona D, Alonso MM, Lecanda F, Pineda-Lucena A, Prósper F, Sanmamed MF, Calvo A, Martinez-Climent JA, Pio R.   +22 more
europepmc   +1 more source

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models. [PDF]

Blood Adv
Kannan S, Li Y, Baran N, Yang X, Ghotbaldini S, Zhang Tatarata Q, Yoshimura S, Li Z, Hsiao Y, Balachander S, Andersen CL, Cidado J, Yu J, Jain N, Yang JJ, Konopleva M.   +15 more
europepmc   +1 more source

Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway. [PDF]

Cancer Lett
Xue Y, Chen T, Ma Z, Pu X, Xu J, Zhai S, Du X, Ji Y, Simon MC, Zhai W, Xue W.   +10 more
europepmc   +1 more source